Broker Forecast - UBS issues a broker note on Synthomer

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

UBS today upgrades its investment rating on Synthomer (LON:SYNT) to neutral (from sell) and cut its price target to 310p (from 326p).

Broker Forecasts data provided by www.sharesmagazine.co.uk